Women in women’s health / Roundup / 30 September 2026
Warnings come off, money moves, menopause on the record
The FDA starts pulling the black-box warning off hormone therapy. Congress holds its first menopause hearing. Money moves across midlife women's health. Two founders from the index are in it.
From the index
2Just funded
301USAXella HealthKelly LacobDiagnostics that read menstrual fluid and blood across fertility, hormones and perimenopause.Raised $3.7M pre-seed, led by Precursor Ventures.02CanadaCoralFiona Lake WaslanderA virtual clinic that puts hormones, metabolism and weight care in one place for midlife women.Added $4M CAD, over $8M CAD raised in total.03USAOsteoboost HealthLaura YeciesAn FDA-cleared wearable that treats low bone density after menopause with vibration therapy.Raised $8M, led by Ambit Health Ventures.
The news
6- FDA begins removing black-box warnings from menopause hormone therapyThe boxed warning that sat on hormone therapy since the Women's Health Initiative is coming off. Only the endometrial-cancer warning stays, for estrogen-alone systemic products.FDA · November 2025
- US Congress holds its first hearing on the menopause care gapThe Senate Special Committee on Aging held its first menopause hearing. It put the gap on the record: menopause drew $78M in research in 2025, a new men's-health category got $768M.Femtech Insider · 2026
- UK launches a £1.5M femtech fund in its renewed Women's Health Strategy£1.5M to help the NHS actually buy femtech, part of England's renewed Women's Health Strategy.Femtech Insider · April 2026
- UK employers to report menopause support from April 2026From April 2026, employers with 250-plus staff are asked to publish their menopause support. Mandatory from 2027.Stylist · 2026
- Hormone therapy linked to far lower risk of low bone densityNew ENDO 2026 data: women on hormone therapy were far less likely to have low bone density.Medical News Today · 2026
- Next Phase Femtech launches with €1.6M to test menopause tools€1.6M, EU-funded. A Danish-Swedish programme will trial three menopause tools with clinicians and back 30 more women's-health companies.Femtech Insider · 2026
A curated roundup, not a ranking or an endorsement. Every item links to its source.